RIP-FX (MK-2866 GW-501516 SR-9009) | GENETIXX LABORATORIES
RIP-FX (MK-2866 GW-501516 SR-9009) | GENETIXX LABORATORIES
RIP-FX
MK-2866 / GW-501516 / SR-9009
Product Overview
RIP-FX (formerly known as Shr3d by Matrix labs) by GENETIXX LABORATORIES is a multi-compound research formulation combining MK-2866 (Ostarine), GW-501516 (Cardarine), and SR-9009 (Stenabolic).
These compounds interact with different biological pathways associated with androgen receptor signalling, metabolic regulation, and circadian rhythm pathways. Because of their varied mechanisms of action, they are sometimes explored together in research models examining body composition signalling and metabolic activity.
RIP-FX provides a structured capsule formulation designed for controlled laboratory environments investigating multi-pathway metabolic and performance-related signalling.
Research Focus
In research settings, compounds contained in RIP-FX are commonly explored in relation to:
• Lean tissue preservation pathways
• Energy metabolism and fatty-acid utilisation
• Endurance and physical conditioning
• Circadian rhythm and metabolic signalling
• Body composition related research
Because these compounds influence different receptor systems, they are sometimes examined together in experimental models studying compound interaction across multiple metabolic pathways.
Compound Profile
MK-2866 (Ostarine)
MK-2866 is a selective androgen receptor modulator studied for its interaction with androgen receptors in muscle and bone tissue and its relationship with lean tissue signalling pathways.
GW-501516 (Cardarine)
GW-501516 is a PPAR-δ agonist widely discussed in metabolic research involving fatty-acid metabolism and endurance-related physiological processes.
SR-9009 (Stenabolic)
SR-9009 interacts with REV-ERB nuclear receptors, which are involved in regulating circadian rhythm and metabolic activity. Research has explored its relationship with energy metabolism and endurance signalling pathways.
Product Format
Caps per container: 60
2 capsules contain:
RIP-FX – 80mg total
• MK-2866 – 30mg
• GW-501516 – 30mg
• SR-9009 – 20mg
Other ingredients:
Gelatin (capsule), Magnesium Stearate, Silicon Dioxide
Why RIP-FX
RIP-FX combines three research compounds associated with androgen receptor signalling, metabolic regulation, and circadian rhythm pathways. The formulation allows research environments to explore compound interaction across multiple biological systems within a single structured capsule format.
SARMs — RESEARCH USE ONLY
This product is supplied strictly for laboratory research only. It is not approved for human consumption and must not be used as a food supplement or medicine. JW Supplements™ does not provide instructions or dosage guidance for human use.
⚠️ IMPORTANT PRODUCT INFORMATION
Please read the product description and any product-specific warnings before purchasing. Products have different intended purposes and restrictions; refer to the information for the individual product.
Foods and supplements: Before consumption, read the ingredients, allergen information and warnings on the product packaging. JW Supplements™ does not provide personalised medical advice.
Food supplements: Follow the labelled directions and do not exceed the recommended daily intake. Food supplements should not replace a varied, balanced diet and a healthy lifestyle. Consult a qualified healthcare professional before taking a supplement if you have a medical condition, take medication, are pregnant or breastfeeding, or are unsure about suitability.
Topical products: Not for oral consumption. Follow the product-specific purpose, restrictions and warnings. Products identified as research-only must not be applied to people.
Age restriction: JW Supplements™ restricts sales to individuals aged 18 or over.
Storage: Follow the storage instructions on the packaging. Keep out of reach of children and pets.
For enquiries, contact enquiries@jwsupplements.co.uk.
Share
